{"id":"NCT02327351","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","briefTitle":"TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID","officialTitle":"Phase II/III Study of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated and Haploidentical Donors After TCR Alfa Beta Negative Selection in Pediatric Patients With Primary Immunodeficiency Diseases","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-07","primaryCompletion":"2017-12","completion":"2018-06","firstPosted":"2014-12-30","resultsPosted":"2021-02-26","lastUpdate":"2021-02-26"},"enrollment":98,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Primary Immune Deficiency Disorder","Hematopoietic Stem Cell Transplantation"],"interventions":[{"type":"OTHER","name":"Biological: TCR alfa beta T cell depletion","otherNames":[]}],"arms":[{"label":"TCR alfa beta depletion","type":"EXPERIMENTAL"}],"summary":"Treatment Study to assess of safety and efficiency of T cells receptor (TCR) alfa beta depleted graft for hematopoietic stem cell transplantation (HSCT) from haploidentical and unrelated donors in patients with primary immunodeficiency diseases","primaryOutcome":{"measure":"Overall Survival","timeFrame":"1 year after HSCT","effectByArm":[{"arm":"TCR Alfa Beta Depletion","deltaMin":86,"sd":null},{"arm":"Matched Unrelated Donor","deltaMin":86,"sd":null},{"arm":"HLA-mismatched Related Donor","deltaMin":87,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":"0.95"}]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":1,"countries":["Russia"]},"refs":{"pmids":["26187864"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":98},"commonTop":[]}}